- Italy and Switzerland Ban Novartis Flu Vaccines!
by Lisa Garber Activist Post
Amid political controversy, the Italian government took the highroad last week by suspending sales of flu vaccines when their quality and safety were called into question.
Novartis AG (NOVN) told Italian and Swiss authorities that their products were safe, although the shots did contain particle buildup. Citing Novartis’ failure to provide adequate information for the safe sale of the shots, however, the Italian Health Ministry has banned the 488,000 doses in question.
Swiss drug regulator Swissmedic followed Italy’s example and halted distribution of the vaccines just in case. Novartis is based in Basel, Switzerland. No illnesses have been reported—a far different outcome than the fungus-contaminated steroids spreading meningitis across the United States.
Delayed Notification to Authorities
Italian Health Minister Renato Balduzzi met Novartis executives late last week to discuss the company’s delayed notification of proper authorities. (Novartis knew of the buildup back in early July. The company said in a statement that particles can occur in vaccines and that they are “confident that there is no impact on safety or efficacy of the vaccine.”
This, of course, smacks of the same kind of confidence Monsanto has about the safety of its 2,4-D and 2,4,5-T herbicides (half the recipe for Agent Orange) and genetically modified crops. One wonders why, then, they paid $93 million in a settlement to residents of Nitro, West Virginia for dioxin contamination and related injuries. An incensed biotech scientist did recently say GMOs’ ability to cause fertility problems was ‘awesome,’ as well. Some corporations just see the world in terms of dollar signs.